Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 41,396 shares at $19.36 ($801K) on 2016-03-24, disclosed to the SEC on 2016-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.36 | 20,548 | $398K | 49.6% |
| 2 | $19.36 | 20,548 | $398K | 49.6% |
| 3 | $19.48 | 300 | $6K | 0.7% |
| Total | $19.36 avg | 41,396 | $801K | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |